For the Inventor, By the Inventor

Enter assignee name

Bethesda, MD, United States of America

National Institutes of Health, a Component of the US Dept. of Health & Human Services

USPTO Granted Patents = 3,435

CIPO Patents = 217

EPO Patents = 851

Trademarks = 242

Forward Citations = 24,252

Loading Chart...

Loading Chart...

5,271 inventors (with patents filed for the assignee):

Steven A Rosenberg (117 out of 139 patents)

Dimiter Stanchev Dimitrov (89 out of 97 patents)

Ira H Pastan (73 out of 126 patents)

4. Jeffrey Schlom (71 out of 85 patents)

5. Brian R Murphy (66 out of 84 patents)

6. Peter L Collins (53 out of 62 patents)

7. Dennis M Klinman (51 out of 54 patents)

8. Robert H Purcell (50 out of 77 patents)

9. Gary J Nabel (48 out of 108 patents)

10. Stephen Whitehead (44 out of 142 patents)

11. Peter D Kwong (44 out of 51 patents)

12. Zhongyu Zhu (43 out of 50 patents)

13. John R Mascola (42 out of 45 patents)

14. Barney S Graham (41 out of 43 patents)

15. Curtis C Harris (38 out of 58 patents)

3,435 patents: Sort by Forward Citations

1. 12481009 - Motor for a MR elastography transducer (2025-11-25),

2. 12479838 - D3 receptor agonist compounds; methods of preparation; intermediates thereof; and methods of use thereof (2025-11-25),

3. 12479812 - Fatty acid derivatives and their use (2025-11-25),

4. 12473307 - Method of preparing zirconium-89 oxine complex (2025-11-18),

5. 12473251 - Crystal forms and methods of synthesis of (2R, 6R)-hydroxynorketamine and (2S, 6S)-hydroxynorketamine (2025-11-18),

6. 12458691 - HIV-1 ENV fusion peptide immunogens and their use (2025-11-04),

7. 12458683 - Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use (2025-11-04),

8. 12458654 - Methods of conditioning patients for T cell therapy (2025-11-04),

9. 12453780 - Monoclonal antibodies specific for fibroblast growth factor receptor 4 (FGFR4) and methods of their use (2025-10-28),

10. 12448604 - Methods of producing modified natural killer cells and methods of use (2025-10-21),

11. 12448428 - HLA class II-restricted t cell receptors against RAS with G12R mutation (2025-10-21),

12. 12447140 - Ketone bodies and ketone body esters as blood lipid lowering agents (2025-10-21),

13. 12441778 - T cell receptors recognizing HLA-A1-restricted MAGE-A3 (2025-10-14),

14. 12440580 - Adeno-associated virus vectors encoding modified G6PC and uses thereof (2025-10-14),

15. 12435113 - Prefusion PIV F immunogens and their use (2025-10-07),

The National Institutes of Health (NIH) is a component of the U.S. Department of Health and Human Services. It is the nation's medical research agency, making important discoveries that improve health and save lives. NIH supports scientific studies and research across various fields, including cancer, infectious diseases, and mental health. With a mission to enhance health, lengthen life, and reduce illness and disability, NIH plays a crucial role in advancing medical knowledge and innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

3,435 Patents

#2 in Bethesda, MD

#3 in Maryland

#122 in US

#261 in the World

Bethesda, MD, United States of America

National Institutes of Health, a Component of the US Dept. of Health & Human Services

Forward Citations = 24,252

5,271 inventors:

Steven A Rosenberg (117 out of 139 patents)

Dimiter Stanchev Dimitrov (89 out of 97 patents)

Ira H Pastan (73 out of 126 patents)

4. Jeffrey Schlom (71 out of 85 patents)

5. Brian R Murphy (66 out of 84 patents)

Please report any incorrect information to support@idiyas.com

Loading…